Technical Analysis for ELDN - Eledon Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
A 5.30 13.98% 0.65
ELDN closed up 13.98 percent on Friday, November 1, 2024, on 3.06 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Nov 7
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
New 52 Week High Strength 0.00%
Parabolic Rise Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakout about 18 hours ago
Up 2 ATRs about 18 hours ago
Rose Above Previous Day's High about 23 hours ago
New 52 Week High about 23 hours ago
2x Volume Pace about 23 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Eledon Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing products for patients with disorders of ear, nose, and throat. The company's lead product is OP0201, a surfactant-based nasal aerosol drug-device combination product for patients at risk for, or with, otitis media (OM) (middle ear inflammation with or without infection). It also has a foam-based drug delivery technology OP0101 and OP0102 that could be used to deliver drugs into the ear, nose, and sinus cavities. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2021. Eledon Pharmaceuticals, Inc. is headquartered in Irvine, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Health Sciences Medication Infection Disorders Sinus Audiology Pediatrics Otorhinolaryngology Pernix Therapeutics Holdings

Is ELDN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.54
52 Week Low 1.07
Average Volume 371,075
200-Day Moving Average 2.42
50-Day Moving Average 2.88
20-Day Moving Average 3.27
10-Day Moving Average 3.77
Average True Range 0.38
RSI (14) 89.70
ADX 42.17
+DI 44.29
-DI 3.92
Chandelier Exit (Long, 3 ATRs) 4.39
Chandelier Exit (Short, 3 ATRs) 3.59
Upper Bollinger Bands 4.68
Lower Bollinger Band 1.86
Percent B (%b) 1.22
BandWidth 86.12
MACD Line 0.48
MACD Signal Line 0.27
MACD Histogram 0.2103
Fundamentals Value
Market Cap 128.25 Million
Num Shares 24.2 Million
EPS -5.44
Price-to-Earnings (P/E) Ratio -0.97
Price-to-Sales 0.00
Price-to-Book 0.45
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.62
Resistance 3 (R3) 6.55 6.05 6.40
Resistance 2 (R2) 6.05 5.71 6.08 6.33
Resistance 1 (R1) 5.67 5.50 5.86 5.74 6.25
Pivot Point 5.17 5.17 5.26 5.20 5.17
Support 1 (S1) 4.79 4.83 4.98 4.86 4.35
Support 2 (S2) 4.29 4.62 4.32 4.27
Support 3 (S3) 3.91 4.29 4.20
Support 4 (S4) 3.98